Dentists in Barceloneta, PR Accepting Medicare

9 Dentists found. Showing 1 - 9

Dr. Carlos J Robles, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1 Cruce Davila Carr. #2, Barceloneta, PR 00617 Phone: 787-970-0000

Mrs. Gretchen N Gay, DMD Dentist Medicare: Medicare Enrolled Practice Location: Georgetti #13, Suite #3, Barceloneta, PR 00617 Phone: 787-846-7247    Fax: 787-846-7247

Mr. Pablo R Amador, DMD Dentist Medicare: Medicare Enrolled Practice Location: 13 Escobar Ave, Barceloneta, PR 00617 Phone: 787-846-5010    Fax: 787-846-5010

Dr. Jessica Milagras Amador, DMD Dentist Medicare: Medicare Enrolled Practice Location: Escobar Avenue 13, Barceloneta, PR 00617 Phone: 787-846-5010    Fax: 787-846-5010

Dr. Norma M Martinez, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 9 Carr 140, Barceloneta, PR 00617 Phone: 787-846-6178    Fax: 787-846-6178

Mrs. Ileane Amador, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: Ave Escobar #13, Barceloneta, PR 00617 Phone: 787-846-5010    Fax: 787-846-5010

Dr. Mario A Sierra, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1 Calle Tomas Davila, Barceloneta, PR 00617 Phone: 787-846-0331

Dr. Luis Ramon Santos-rivera, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: Road Num. 2 - Km 57.2 -cruce Davila, Barceloneta, PR 00617 Phone: 787-846-5215    Fax: 787-846-5215

Liselie Reyes Dentist Medicare: Medicare Enrolled Practice Location: Carr. #2 Km. 55.5 Bo. Palenque, Barceloneta, PR 00617 Phone: 787-846-0352    Fax: 787-846-0352

News Archive

Study suggests potential therapeutic role of aspirin in inhibiting vestibular schwannoma growth

Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated, for the first time, that aspirin intake correlates with halted growth of vestibular schwannomas (also known as acoustic neuromas), a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

Women more likely than men to die from a heart attack due to treatment disparity

Study shows women are more likely than men to die during the year following a heart attack as they are less likely to be offered recommended treatments.

BioAlliance Pharma launches Oravig drug in the U.S. market

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announces the launch in the United States of Oravig® (known as Loramyc® in Europe) for the treatment of oropharyngeal candidiasis (OPC) in adults by its commercial partner, Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc..

Progestins have tumor-stage specific effects that determine promotion, suppression: Study

Progestins are used in hormone replacement therapies to counteract the negative effects of estrogen on the uterus and reduce the risk of uterine cancer. However, evidence in recent studies and clinical trials has demonstrated that progestins increase the risk of breast cancer. Now, University of Missouri researchers have compared four types of progestins used in hormone replacement therapies and found significantly different outcomes on the progression of breast cancer in an animal model depending on the type of progestins used.

Read more Medical News

› Verified 1 days ago